...
首页> 外文期刊>Tumor Biology >Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action
【24h】

Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action

机译:三氧化二砷诱导急性早幼粒细胞白血病细胞中miRNA基因表达模式的改变:解释砷多靶点作用的可能机制

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

MicroRNAs (miRNAs) are involved in cancer pathogenesis, apoptosis, and cell growth, and these miRNAs are thought to be functional as oncogenes and/or tumor suppressors in the gene regulatory networks. We studied the potential contribution of miRNAs in acute promyelocytic leukemia (APL) cell NB4 during the apoptosis induction by arsenic trioxide (ATO). The apoptotic effects of ATO on the NB4 cell line at a pharmacological dose (2 μM) was verified using cell growth and viability assays, MTT assay, BrdU cell proliferation assay, flow cytometric analysis, and caspase-3 activity assay. miRNAs from untreated and 2 μM ATO-treated NB4 cell line were extracted, purified, and converted to complementary DNAs. Differential expressions of 88 cancer-related miRNAs were analyzed by real-time reverse transcription PCR using miRNA PCR cancer-array system. After normalizing to the average Ct value of three housekeeping genes in the array (U6, SNORD47, and SNORD48), the fold change of miRNAs was calculated in the ATO-treated cells as compared to untreated. Among the 88 cancer-focused miRNAs, 51 miRNAs were found to be differentially expressed more than 2-fold after ATO treatment. Of these, 48 miRNAs were upregulated up to 21.65-fold changes, while three miRNAs were downregulated up to 5.19-fold changes. By screening the literature, a majority of these upregulated miRNAs were found to have tumor and/or metastatic suppressors’ functions associated with cell cycle arrest and apoptosis, as well as inhibition of angiogenesis, invasion, and metastasis. Our results demonstrate that ATO, at the relevant concentration, modulate a substantial number of cancer-related miRNAs in APL cell line; most of these are known to function as a tumor and/or metastatic suppressors and have confirmed targets involved in cell cycle arrest and apoptosis. The results of this study support the hypothesis that miRNAs may play a mediatory role in eliciting the multi-target and pleiotropic action of ATO.
机译:MicroRNA(miRNA)参与癌症的发病机理,凋亡和细胞生长,这些miRNA被认为在基因调控网络中起癌基因和/或肿瘤抑制子的作用。我们研究了miRNA在三氧化二砷(ATO)诱导凋亡过程中对急性早幼粒细胞白血病(APL)NB4细胞的潜在贡献。使用细胞生长和生存力测定,MTT测定,BrdU细胞增殖测定,流式细胞术分析和caspase-3活性测定,以药理剂量(2μM)验证ATO对NB4细胞系的凋亡作用。提取,纯化未经处理的和2μMATO处理的NB4细胞系的miRNA,并将其转化为互补DNA。使用miRNA PCR癌症阵列系统通过实时逆转录PCR分析88种与癌症相关的miRNA的差异表达。将阵列中三个持家基因(U6,SNORD47和SNORD48)的平均Ct值标准化后,计算ATO处理的细胞与未处理的细胞相比,miRNA的倍数变化。在88种以癌症为中心的miRNA中,发现51种miRNA在ATO治疗后差异表达超过2倍。其中,48个miRNA被上调至21.65倍变化,而三个miRNA被下调至5.19倍变化。通过文献筛选,发现大多数这些上调的miRNA具有与细胞周期停滞和凋亡相关的肿瘤和/或转移抑制子功能,以及对血管生成,侵袭和转移的抑制作用。我们的结果表明,ATO在相关浓度下可调节APL细胞系中大量与癌症相关的miRNA。这些中的大多数已知起肿瘤和/或转移抑制子的作用,并已确定涉及细胞周期阻滞和凋亡的靶标。这项研究的结果支持以下假设:miRNA可能在引起ATO的多靶点和多效性作用中起中介作用。

著录项

  • 来源
    《Tumor Biology》 |2012年第1期|157-172|共16页
  • 作者单位

    Hematology Oncology and Stem Cell Transplantation Research Center Shariati Hospital Tehran University of Medical Sciences Tehran Iran;

    Hematology Oncology and Stem Cell Transplantation Research Center Shariati Hospital Tehran University of Medical Sciences Tehran Iran;

    Hematology Oncology and Stem Cell Transplantation Research Center Shariati Hospital Tehran University of Medical Sciences Tehran Iran;

    Hematology Oncology and Stem Cell Transplantation Research Center Shariati Hospital Tehran University of Medical Sciences Tehran Iran;

    Hematology Oncology and Stem Cell Transplantation Research Center Shariati Hospital Tehran University of Medical Sciences Tehran Iran;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Acute promyelocytic leukemia; Arsenic trioxide; MicroRNA; Apoptosis;

    机译:急性早幼粒细胞白血病;三氧化二砷;MicroRNA;细胞凋亡;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号